Study finds new evidence of health threat from chemicals in marijuana and tobacco smoke

January 11, 2021

Scientists at Dana-Farber Cancer Institute and the Centers for Disease Control and Prevention have uncovered new evidence of the potential health risks of chemicals in tobacco and marijuana smoke.

In a study published online today by , the researchers report that people who smoked only marijuana had several smoke-related toxic chemicals in their blood and urine, but at lower levels than those who smoked both tobacco and marijuana or tobacco only. Two of those chemicals, acrylonitrile and acrylamide, are known to be toxic at high levels. The investigators also found that exposure to acrolein, a chemical produced by the combustion of a variety of materials, increases with tobacco smoking but not marijuana smoking and contributes to cardiovascular disease in tobacco smokers.

The findings suggest that high acrolein levels may be a sign of increased risk of cardiovascular disease and that reducing exposure to the chemical could lower that risk. This is particularly important for people infected with HIV, the virus that causes AIDS, given high rates of tobacco smoking and the increased risk of heart disease in this group.

"Marijuana use is on the rise in the United States with a growing number of states legalizing it for medical and nonmedical purposes - including five additional states in the 2020 election. The increase has renewed concerns about the potential health effects of marijuana smoke, which is known to contain some of the same toxic combustion products found in tobacco smoke," said the senior author of the study,

The study involved 245 HIV-positive and HIV-negative participants in three studies of HIV infection in the United States. (Studies involving people with HIV infection were used because of high tobacco and marijuana smoking rates in this group.) The researchers collected data from participants' medical records and survey results and analyzed their blood and urine samples for substances produced by the breakdown of nicotine or the combustion of tobacco or marijuana. Combining these datasets enabled them to trace the presence of specific toxic chemicals to tobacco or marijuana smoking and to see if any were associated with an increased risk of heart disease.

The investigators found that participants who exclusively smoked marijuana had higher blood and urine levels of several smoke-related toxic chemicals such as naphthalene, acrylamide, and acrylonitrile metabolites than non-smokers did. However, the concentrations of these substances were lower in marijuana-only smokers than in tobacco smokers.

Investigators also found that acrolein metabolites - substances generated by the breaking down of acrolein - were elevated in tobacco smokers but not marijuana smokers. This increase was associated with cardiovascular disease regardless of whether individuals smoked tobacco or had other risk factors.

"Our findings suggest that high acrolein levels may be used to identify patients with increased cardiovascular risk," Gabuzda said, "and that reducing acrolein exposure from tobacco smoking and other sources could be a strategy for reducing risk."
-end-
The first author of the study is David R. Lorenz, PhD, of Dana-Farber. Co-authors are Vikas Misra, MSc, Sukrutha Chettimada, PhD, and Hajime Uno, PhD, of Dana-Farber; Lanqing Wang, PhD, Benjamin C. Blount, PhD, and Vi?ctor R. De Jesu?s, PhD, of the Centers for Disease Control and Prevention; Benjamin B. Gelman, MD, PhD, of the University of Texas; Susan Morgello, MD, of Icahn School of Medicine; and Steven M. Wolinsky, MD, of Northwestern University.

The study was supported by the National Institutes of Health (grants R01 DA040391 and DA046203); the National Institute of Mental Health (NIMH) and National Institute of Neurological Disorders and Stroke (NINDS) (grants U24MH100931, U24MH100930, U24MH100929, U24MH100928, U24MH100925, MH062512, HHS-N-271-2010-00036C, and HHSN271201000030C); the National Institute of Allergy and Infectious Diseases (grants U01- AI35039, U01-AI35040, U01-AI35041, U01- AI35042, and UM1-AI35043); the National Cancer Institute; National Institute on Drug Abuse; and National Institute of Mental Health. MACS data collection is also supported by UL1- TR000424.

Dana-Farber Cancer Institute

Related Tobacco Articles from Brightsurf:

UC studies tobacco use, cancer connection
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

'Best' hospitals should be required to deliver tobacco treatment
A UCLA-led report published today in the Journal of the American Medical Association Internal Medicine exposes what the authors call a weakness in the high-profile 'Best Hospitals Honor Roll' published annually by US News and World Report.

Small shops, heavy advertisers less likely to ID for tobacco
'Our findings suggest that certain types of stores -- tobacco shops, convenience stores and those with a lot of tobacco advertising -- are more likely to sell tobacco to a young person without checking his or her ID.'

Youth smoking and vaping: What does it mean for tobacco control
New research from PIRE/PRC features analysis of in-depth, qualitative interviews with young vapers in California between 15 and 25.

Truth telling about tobacco and nicotine
In 'Truth Telling about Tobacco and Nicotine,' PRC researchers explain that, although there is agreement among researchers about evidence that vaping can be less harmful than combustible cigarettes, the tobacco control community remains divided about how to communicate -- or even whether to communicate -- information about the relative risks of tobacco and nicotine products.

A 'joint' problem: Investigating marijuana and tobacco co-use
A survey of marijuana and tobacco co-users by Medical University of South Carolina investigators found that co-users with high degree of interrelatedness between their use of the two substances had greater tobacco dependence and smoked more cigarettes per day.

How genes affect tobacco and alcohol use
A new study gives insight into the complexity of genetic and environmental factors that compel some of us to drink and smoke more than others.

Tobacco use linked with higher use of opioids and sedatives
Tobacco is a known risk factor for the misuse of prescription opioids.

Changes in flavored tobacco product use among youth tobacco users
Self-reportedĀ use of flavored tobacco products by middle and high school students decreased from 2014 to 2016 but climbed back up in 2017 in an analysis of national survey data.

Heated tobacco product claims by tobacco industry scrutinized by UCSF researchers
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry's own data and are likely to be misunderstood by consumers, according to research published in a special issue of Tobacco Control.

Read More: Tobacco News and Tobacco Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.